Published in Nat Mater on November 02, 2008
Complexity in biomaterials for tissue engineering. Nat Mater (2009) 4.38
Macroporous nanowire nanoelectronic scaffolds for synthetic tissues. Nat Mater (2012) 2.57
Carbon-nanotube-embedded hydrogel sheets for engineering cardiac constructs and bioactuators. ACS Nano (2013) 2.23
Nanowired three-dimensional cardiac patches. Nat Nanotechnol (2011) 1.76
Biomimetic platforms for human stem cell research. Cell Stem Cell (2011) 1.58
Bioengineering Human Myocardium on Native Extracellular Matrix. Circ Res (2015) 1.53
25th anniversary article: Rational design and applications of hydrogels in regenerative medicine. Adv Mater (2014) 1.52
Engineering microscale topographies to control the cell-substrate interface. Biomaterials (2012) 1.51
Characterization of the complete fiber network topology of planar fibrous tissues and scaffolds. Biomaterials (2010) 1.51
Mesoscopic hydrogel molding to control the 3D geometry of bioartificial muscle tissues. Nat Protoc (2009) 1.45
Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch. PLoS One (2015) 1.43
Flexible shape-memory scaffold for minimally invasive delivery of functional tissues. Nat Mater (2017) 1.39
The effect of anisotropic collagen-GAG scaffolds and growth factor supplementation on tendon cell recruitment, alignment, and metabolic activity. Biomaterials (2011) 1.37
Microfabrication of complex porous tissue engineering scaffolds using 3D projection stereolithography. Biomaterials (2012) 1.34
Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. Biomaterials (2011) 1.30
Biomimetic electrospun nanofibrous structures for tissue engineering. Mater Today (Kidlington) (2013) 1.26
Bioengineering heart muscle: a paradigm for regenerative medicine. Annu Rev Biomed Eng (2011) 1.26
Advanced material strategies for tissue engineering scaffolds. Adv Mater (2009) 1.18
Paramagnetic levitational assembly of hydrogels. Adv Mater (2012) 1.18
Electrospun fibrous scaffolds with multiscale and photopatterned porosity. Macromol Biosci (2010) 1.14
Biomaterial strategies for alleviation of myocardial infarction. J R Soc Interface (2011) 1.13
Functional cardiac tissue engineering. Regen Med (2012) 1.07
Hybrid PGS-PCL microfibrous scaffolds with improved mechanical and biological properties. J Tissue Eng Regen Med (2011) 1.07
Patching the heart: cardiac repair from within and outside. Circ Res (2013) 1.04
Highly Elastic Micropatterned Hydrogel for Engineering Functional Cardiac Tissue. Adv Funct Mater (2013) 1.04
Engineered hybrid cardiac patches with multifunctional electronics for online monitoring and regulation of tissue function. Nat Mater (2016) 1.04
Neonatal mouse-derived engineered cardiac tissue: a novel model system for studying genetic heart disease. Circ Res (2011) 1.02
3D structural patterns in scalable, elastomeric scaffolds guide engineered tissue architecture. Adv Mater (2013) 1.01
Biodegradable scaffold with built-in vasculature for organ-on-a-chip engineering and direct surgical anastomosis. Nat Mater (2016) 1.01
The generation of biomolecular patterns in highly porous collagen-GAG scaffolds using direct photolithography. Biomaterials (2011) 1.01
Biomechanics and mechanobiology in functional tissue engineering. J Biomech (2014) 0.99
Biomimetic perfusion and electrical stimulation applied in concert improved the assembly of engineered cardiac tissue. J Tissue Eng Regen Med (2011) 0.99
Combinatorial polymer electrospun matrices promote physiologically-relevant cardiomyogenic stem cell differentiation. PLoS One (2011) 0.99
Micropatterning Alginate Substrates for in vitro Cardiovascular Muscle on a Chip. Adv Funct Mater (2013) 0.98
Controlling the structural and functional anisotropy of engineered cardiac tissues. Biofabrication (2014) 0.98
The development of collagen-GAG scaffold-membrane composites for tendon tissue engineering. Biomaterials (2011) 0.98
PGS:Gelatin nanofibrous scaffolds with tunable mechanical and structural properties for engineering cardiac tissues. Biomaterials (2013) 0.98
Geometry and force control of cell function. J Cell Biochem (2009) 0.98
Functional consequences of a tissue-engineered myocardial patch for cardiac repair in a rat infarct model. Tissue Eng Part A (2014) 0.97
Hydrogel-coated microfluidic channels for cardiomyocyte culture. Lab Chip (2013) 0.97
Micro- and nanoscale control of the cardiac stem cell niche for tissue fabrication. Tissue Eng Part B Rev (2009) 0.97
Cardiac applications for human pluripotent stem cells. Curr Pharm Des (2009) 0.97
Nanoelectronics-biology frontier: From nanoscopic probes for action potential recording in live cells to three-dimensional cyborg tissues. Nano Today (2013) 0.96
Micro-arrayed human embryonic stem cells-derived cardiomyocytes for in vitro functional assay. PLoS One (2012) 0.96
The significance of pore microarchitecture in a multi-layered elastomeric scaffold for contractile cardiac muscle constructs. Biomaterials (2010) 0.95
Intramyocardial injection of platelet gel promotes endogenous repair and augments cardiac function in rats with myocardial infarction. J Am Coll Cardiol (2012) 0.95
Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy. Nat Biotechnol (2014) 0.95
From cardiac tissue engineering to heart-on-a-chip: beating challenges. Biomed Mater (2015) 0.94
Micropattern width dependent sarcomere development in human ESC-derived cardiomyocytes. Biomaterials (2014) 0.93
Experimental and computational investigation of altered mechanical properties in myocardium after hydrogel injection. Ann Biomed Eng (2013) 0.93
From single fiber to macro-level mechanics: A structural finite-element model for elastomeric fibrous biomaterials. J Mech Behav Biomed Mater (2014) 0.93
Material strategies for creating artificial cell-instructive niches. Curr Opin Biotechnol (2012) 0.93
Bone marrow-derived mesenchymal stem cells in fibrin augment angiogenesis in the chronically infarcted myocardium. Regen Med (2009) 0.93
Combined technologies for microfabricating elastomeric cardiac tissue engineering scaffolds. Macromol Biosci (2010) 0.93
Engineering the heart: evaluation of conductive nanomaterials for improving implant integration and cardiac function. Sci Rep (2014) 0.92
Engineered cell-laden human protein-based elastomer. Biomaterials (2013) 0.92
The expanding world of tissue engineering: the building blocks and new applications of tissue engineered constructs. IEEE Rev Biomed Eng (2012) 0.92
A bioprosthetic ovary created using 3D printed microporous scaffolds restores ovarian function in sterilized mice. Nat Commun (2017) 0.91
Mechanisms of greater cardiomyocyte functions on conductive nanoengineered composites for cardiovascular application. Int J Nanomedicine (2012) 0.91
Concise review: cell therapy and tissue engineering for cardiovascular disease. Stem Cells Transl Med (2012) 0.90
Effect of biodegradation and de novo matrix synthesis on the mechanical properties of valvular interstitial cell-seeded polyglycerol sebacate-polycaprolactone scaffolds. Acta Biomater (2012) 0.89
A biocompatible endothelial cell delivery system for in vitro tissue engineering. Cell Transplant (2009) 0.89
A biodegradable microvessel scaffold as a framework to enable vascular support of engineered tissues. Biomaterials (2013) 0.89
Bioactive scaffolds for engineering vascularized cardiac tissues. Macromol Biosci (2010) 0.88
The stimulation of the cardiac differentiation of mesenchymal stem cells in tissue constructs that mimic myocardium structure and biomechanics. Biomaterials (2011) 0.88
Progress of key strategies in development of electrospun scaffolds: bone tissue. Sci Technol Adv Mater (2012) 0.88
Tough and flexible CNT-polymeric hybrid scaffolds for engineering cardiac constructs. Biomaterials (2014) 0.88
Biomaterial based cardiac tissue engineering and its applications. Biomed Mater (2015) 0.88
Model systems for cardiovascular regenerative biology. Cold Spring Harb Perspect Med (2013) 0.87
Materials science and tissue engineering: repairing the heart. Mayo Clin Proc (2013) 0.87
Combinatorial polymer matrices enhance in vitro maturation of human induced pluripotent stem cell-derived cardiomyocytes. Biomaterials (2015) 0.86
Three-dimensional elastomeric scaffolds designed with cardiac-mimetic structural and mechanical features. Tissue Eng Part A (2012) 0.86
Cardiac tissue engineering: implications for pediatric heart surgery. Pediatr Cardiol (2009) 0.86
The evolution of biomaterials. Interview by Alison Stoddart and Victoria Cleave. Nat Mater (2009) 0.86
A novel family of biodegradable poly(ester amide) elastomers. Adv Mater (2011) 0.86
Myocardial tissue engineering: in vitro models. Cold Spring Harb Perspect Med (2014) 0.85
Engineered cardiac tissues. Curr Opin Biotechnol (2011) 0.85
Direct 3D bioprinting of perfusable vascular constructs using a blend bioink. Biomaterials (2016) 0.85
Finite element analysis of an accordion-like honeycomb scaffold for cardiac tissue engineering. J Biomech (2010) 0.84
Layer-by-layer assembly of 3D tissue constructs with functionalized graphene. Adv Funct Mater (2014) 0.84
Structural and biomechanical characterizations of porcine myocardial extracellular matrix. J Mater Sci Mater Med (2012) 0.84
Reduced Graphene Oxide-GelMA Hybrid Hydrogels as Scaffolds for Cardiac Tissue Engineering. Small (2016) 0.84
Highly Elastic and Conductive Human-Based Protein Hybrid Hydrogels. Adv Mater (2015) 0.83
Shear wave vibrometry evaluation in transverse isotropic tissue mimicking phantoms and skeletal muscle. Phys Med Biol (2014) 0.83
The influence of fibrous elastomer structure and porosity on matrix organization. PLoS One (2010) 0.83
Protein tethering into multiscale geometries by covalent subtractive printing. Adv Mater (2011) 0.83
Biomechanical regulation of in vitro cardiogenesis for tissue-engineered heart repair. Stem Cell Res Ther (2013) 0.83
Topological and electrical control of cardiac differentiation and assembly. Stem Cell Res Ther (2013) 0.83
Tri-layered elastomeric scaffolds for engineering heart valve leaflets. Biomaterials (2014) 0.83
Chitin Nanofiber Micropatterned Flexible Substrates for Tissue Engineering(†) J Mater Chem B Mater Biol Med (2013) 0.83
Generation of tissue constructs for cardiovascular regenerative medicine: from cell procurement to scaffold design. Biotechnol Adv (2012) 0.82
Biomaterials-Based Strategies for the Engineering of Mechanically Active Soft Tissues. MRS Commun (2012) 0.82
Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip. Biomaterials (2016) 0.82
Living bacterial sacrificial porogens to engineer decellularized porous scaffolds. PLoS One (2011) 0.82
Embryonic stem cell-based cardiopatches improve cardiac function in infarcted rats. Stem Cells Transl Med (2012) 0.82
Strategies for tissue engineering cardiac constructs to affect functional repair following myocardial infarction. J Cardiovasc Transl Res (2011) 0.82
The spatiotemporal development of intercalated disk in three-dimensional engineered heart tissues based on collagen/matrigel matrix. PLoS One (2013) 0.81
Long-term culture of HL-1 cardiomyocytes in modular poly(ethylene glycol) microsphere-based scaffolds crosslinked in the phase-separated state. Acta Biomater (2011) 0.81
Scalable units for building cardiac tissue. Adv Mater (2014) 0.81
Greater cardiomyocyte density on aligned compared with random carbon nanofibers in polymer composites. Int J Nanomedicine (2014) 0.81
Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med (2008) 10.15
Fiber orientation in the canine left ventricle during diastole and systole. Circ Res (1969) 7.01
Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med (2006) 4.74
A tough biodegradable elastomer. Nat Biotechnol (2002) 4.35
Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A (2004) 4.13
Muscular thin films for building actuators and powering devices. Science (2007) 3.21
Structure and mechanics of healing myocardial infarcts. Annu Rev Biomed Eng (2005) 2.68
Right ventricular infarction. N Engl J Med (1994) 2.48
Medium perfusion enables engineering of compact and contractile cardiac tissue. Am J Physiol Heart Circ Physiol (2003) 2.42
Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng (2006) 2.20
Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am J Physiol (1999) 2.19
Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro. J Cell Sci (2005) 2.07
A small angle light scattering device for planar connective tissue microstructural analysis. Ann Biomed Eng (1997) 2.02
Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng (2006) 2.01
In vivo degradation characteristics of poly(glycerol sebacate). J Biomed Mater Res A (2003) 2.01
Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J (2006) 1.90
Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. Am J Physiol Heart Circ Physiol (2001) 1.90
Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J (2000) 1.74
Measuring fiber alignment in electrospun scaffolds: a user's guide to the 2D fast Fourier transform approach. J Biomater Sci Polym Ed (2008) 1.73
Comparison of 2D fiber network orientation measurement methods. J Biomed Mater Res A (2009) 1.72
Creating alignment and anisotropy in engineered heart tissue: role of boundary conditions in a model three-dimensional culture system. Tissue Eng (2003) 1.69
Microfabrication of poly (glycerol-sebacate) for contact guidance applications. Biomaterials (2005) 1.65
Characterisation of a soft elastomer poly(glycerol sebacate) designed to match the mechanical properties of myocardial tissue. Biomaterials (2008) 1.63
Pre-treatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue. J Biomed Mater Res A (2008) 1.63
Three-Dimensional Microfluidic Tissue-Engineering Scaffolds Using a Flexible Biodegradable Polymer. Adv Mater (2005) 1.49
Microfabrication of three-dimensional engineered scaffolds. Tissue Eng (2007) 1.48
Macroporous elastomeric scaffolds with extensive micropores for soft tissue engineering. Tissue Eng (2006) 1.48
Mechanical properties and remodeling of hybrid cardiac constructs made from heart cells, fibrin, and biodegradable, elastomeric knitted fabric. Tissue Eng (2005) 1.48
Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation (2002) 1.45
Activation of the ERK1/2 cascade via pulsatile interstitial fluid flow promotes cardiac tissue assembly. Tissue Eng (2007) 1.35
Biaxial mechanical properties of passive right ventricular free wall myocardium. J Biomech Eng (1993) 1.34
Micropatterned cell cultures on elastic membranes as an in vitro model of myocardium. Nat Protoc (2006) 1.30
A microfabricated scaffold for retinal progenitor cell grafting. Biomaterials (2007) 1.28
Cultivation in rotating bioreactors promotes maintenance of cardiac myocyte electrophysiology and molecular properties. Tissue Eng (2003) 1.23
A novel perfusion bioreactor providing a homogenous milieu for tissue regeneration. Tissue Eng (2006) 1.20
3-Dimensional configuration of perimysial collagen fibres in rat cardiac muscle at resting and extended sarcomere lengths. J Physiol (1999) 1.15
Coarctectomy reduces neoaortic arch obstruction in hypoplastic left heart syndrome. J Thorac Cardiovasc Surg (2007) 1.12
Guidance of engineered tissue collagen orientation by large-scale scaffold microstructures. J Biomech (2005) 1.09
Co-culture induces alignment in engineered cardiac constructs via MMP-2 expression. Biochem Biophys Res Commun (2008) 1.07
Photocrosslinkable hydrogel for myocyte cell culture and injection. J Biomed Mater Res B Appl Biomater (2007) 1.06
The helical ventricular myocardial band: global, three-dimensional, functional architecture of the ventricular myocardium. Eur J Cardiothorac Surg (2006) 1.04
Insulin-like growth factor-I and slow, bi-directional perfusion enhance the formation of tissue-engineered cardiac grafts. Tissue Eng Part A (2009) 1.02
Assessment of myocardial regional strain and strain rate by tissue tracking in B-mode echocardiograms. Ultrasound Med Biol (2006) 1.01
Effects of regulatory factors on engineered cardiac tissue in vitro. Tissue Eng (2007) 1.00
Regional deformation and contractile function in canine right ventricular free wall. Am J Physiol (1991) 0.99
Seamless tubular poly(glycerol sebacate) scaffolds: high-yield fabrication and potential applications. J Biomed Mater Res A (2008) 0.97
Directional variability of stimulation threshold measurements in isolated guinea pig cardiomyocytes: relationship with orthogonal sequential defibrillating pulses. Pacing Clin Electrophysiol (1990) 0.93
Measurements of the mechanical properties of contracted collagen gels populated with rat fibroblasts or cardiomyocytes. J Artif Organs (2003) 0.93
Homograft valved right ventricle to pulmonary artery conduit as a modification of the Norwood procedure. Circulation (2006) 0.90
A micro-anatomical model of the distribution of myocardial endomysial collagen. Histol Histopathol (2002) 0.89
Electrical stimulation of cardiac myocytes. Ann Biomed Eng (1996) 0.83
Long-term survival after right ventricular infarction. Am J Cardiol (2006) 0.82
Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol (2007) 17.80
Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov (2009) 12.46
Engineering vascularized skeletal muscle tissue. Nat Biotechnol (2005) 7.73
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A (2006) 6.90
Impact of nanotechnology on drug delivery. ACS Nano (2009) 6.87
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol (2008) 6.81
Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci U S A (2006) 6.66
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med (2012) 5.92
Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells. Nat Biotechnol (2004) 5.51
Transdermal drug delivery. Nat Biotechnol (2008) 5.11
Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A (2002) 4.77
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc Natl Acad Sci U S A (2008) 4.57
Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res (2004) 4.56
Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. Am J Epidemiol (2005) 4.55
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol (2008) 4.46
A tough biodegradable elastomer. Nat Biotechnol (2002) 4.35
Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci U S A (2010) 4.25
Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A (2004) 4.13
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials (2006) 4.09
Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med (2005) 4.04
A reversibly switching surface. Science (2003) 3.97
Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol (2011) 3.95
Small-scale systems for in vivo drug delivery. Nat Biotechnol (2003) 3.90
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc Natl Acad Sci U S A (2008) 3.80
Nanoparticle delivery of cancer drugs. Annu Rev Med (2011) 3.75
Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A (2002) 3.66
Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci U S A (2008) 3.62
First-in-human testing of a wirelessly controlled drug delivery microchip. Sci Transl Med (2012) 3.56
Controlled degradation and mechanical behavior of photopolymerized hyaluronic acid networks. Biomacromolecules (2005) 3.44
Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov (2004) 3.41
Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nat Neurosci (2006) 3.35
Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A (2002) 3.35
Treating metastatic cancer with nanotechnology. Nat Rev Cancer (2011) 3.30
Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A (2007) 3.19
Outbreak of adverse reactions associated with contaminated heparin. N Engl J Med (2008) 3.16
Nanotechnological strategies for engineering complex tissues. Nat Nanotechnol (2010) 3.15
Combinatorial development of biomaterials for clonal growth of human pluripotent stem cells. Nat Mater (2010) 3.11
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat Nanotechnol (2012) 3.09
Engineering substrate topography at the micro- and nanoscale to control cell function. Angew Chem Int Ed Engl (2009) 3.09
A biomimetic three-dimensional woven composite scaffold for functional tissue engineering of cartilage. Nat Mater (2007) 3.06
Microengineered hydrogels for tissue engineering. Biomaterials (2007) 2.87
Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci U S A (2003) 2.86
Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew Chem Int Ed Engl (2003) 2.83
The inflammatory responses to silk films in vitro and in vivo. Biomaterials (2005) 2.79
Biodegradable, elastic shape-memory polymers for potential biomedical applications. Science (2002) 2.79
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano (2008) 2.76
Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev (2006) 2.69
Multi-pulse drug delivery from a resorbable polymeric microchip device. Nat Mater (2003) 2.65
A combinatorial polymer library approach yields insight into nonviral gene delivery. Acc Chem Res (2008) 2.63
A biodegradable and biocompatible gecko-inspired tissue adhesive. Proc Natl Acad Sci U S A (2008) 2.58
Macroporous nanowire nanoelectronic scaffolds for synthetic tissues. Nat Mater (2012) 2.57
Light-induced shape-memory polymers. Nature (2005) 2.52
Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study. Circulation (2005) 2.49
Medium perfusion enables engineering of compact and contractile cardiac tissue. Am J Physiol Heart Circ Physiol (2003) 2.42
Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett (2007) 2.40
A vector-free microfluidic platform for intracellular delivery. Proc Natl Acad Sci U S A (2013) 2.40
Development of lipidoid-siRNA formulations for systemic delivery to the liver. Mol Ther (2009) 2.39
An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew Chem Int Ed Engl (2006) 2.38
Bio-inspired polymer composite actuator and generator driven by water gradients. Science (2013) 2.38
Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett (2010) 2.35
Controlling size, shape and homogeneity of embryoid bodies using poly(ethylene glycol) microwells. Lab Chip (2007) 2.30
Biocompatibility and biofouling of MEMS drug delivery devices. Biomaterials (2003) 2.27
Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng (2004) 2.26
Endothelialized microvasculature based on a biodegradable elastomer. Tissue Eng (2005) 2.23
Silk implants for the healing of critical size bone defects. Bone (2005) 2.22
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials (2008) 2.21
Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc Natl Acad Sci U S A (2010) 2.21
Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng (2006) 2.20
Micromolding of shape-controlled, harvestable cell-laden hydrogels. Biomaterials (2006) 2.12
Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed (2007) 2.12
Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circ Res (2007) 2.12
Progress in tissue engineering. Sci Am (2009) 2.08
In vivo engineering of organs: the bone bioreactor. Proc Natl Acad Sci U S A (2005) 2.04
Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines. Nat Mater (2004) 2.03
Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines. Proc Natl Acad Sci U S A (2004) 2.03
Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng (2006) 2.01
In vivo degradation characteristics of poly(glycerol sebacate). J Biomed Mater Res A (2003) 2.01
Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling. Nat Biotechnol (2013) 1.97
Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. J Biomed Mater Res A (2004) 1.94
Measurement and predictors of resilience among community-dwelling older women. J Psychiatr Res (2008) 1.91
Cell docking inside microwells within reversibly sealed microfluidic channels for fabricating multiphenotype cell arrays. Lab Chip (2005) 1.89
Structure/property studies of polymeric gene delivery using a library of poly(beta-amino esters). Mol Ther (2005) 1.87
Synthesis of poly(beta-amino ester)s optimized for highly effective gene delivery. Bioconjug Chem (2003) 1.87
Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett (2009) 1.86
Quantitative and comparative studies of the vocal fold extracellular matrix II: collagen. Ann Otol Rhinol Laryngol (2006) 1.85
A simple soft lithographic route to fabrication of poly(ethylene glycol) microstructures for protein and cell patterning. Biomaterials (2004) 1.84
Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles. Proc Natl Acad Sci U S A (2009) 1.83
New opportunities: the use of nanotechnologies to manipulate and track stem cells. Cell Stem Cell (2008) 1.82
Parallel synthesis and biophysical characterization of a degradable polymer library for gene delivery. J Am Chem Soc (2003) 1.81
Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano Lett (2008) 1.80
A polymer library approach to suicide gene therapy for cancer. Proc Natl Acad Sci U S A (2004) 1.79
Co-culture of human embryonic stem cells with murine embryonic fibroblasts on microwell-patterned substrates. Biomaterials (2006) 1.79
Biomaterial microarrays: rapid, microscale screening of polymer-cell interaction. Biomaterials (2005) 1.78
Fabrication and biocompatibility of polypyrrole implants suitable for neural prosthetics. Biomaterials (2005) 1.78
High-density seeding of myocyte cells for cardiac tissue engineering. Biotechnol Bioeng (2003) 1.77